-
Je něco špatně v tomto záznamu ?
Adamantane - A Lead Structure for Drugs in Clinical Practice
K. Spilovska, F. Zemek, J. Korabecny, E. Nepovimova, O. Soukup, M. Windisch, K. Kuca,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, přehledy
Grantová podpora
NV15-30954A
MZ0
CEP - Centrální evidence projektů
- MeSH
- adamantan analogy a deriváty farmakokinetika terapeutické užití MeSH
- Alzheimerova nemoc farmakoterapie MeSH
- antivirové látky chemie farmakokinetika terapeutické užití MeSH
- chřipka lidská farmakoterapie MeSH
- diabetes mellitus 2. typu farmakoterapie MeSH
- hypoglykemika chemie farmakokinetika terapeutické užití MeSH
- lidé MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
The adamantane moiety is the structural backbone of numerous compounds and its discovery launched a new field of chemistry studying the approaches to the synthesis as well as the physicochemical and biological properties of organic polyhedral compounds with practical application in the pharmaceutical industry. Adamantane derivatives have proven to be very potent compounds in a wide range of applications from systemic to topical therapy. This review summarizes the currently available adamantane derivatives in clinical practice (amantadine, memantine, rimantadine, tromantadine, adapalene, saxagliptin, vildagliptin), focusing on mechanisms of action, pharmacokinetics, pharmacodynamics and clinical trials. The adamantane-based compounds presented in this manuscript have been approved for a wide spectrum of indications (antivirals, antidiabetics and against Alzheimer's and Parkinson's disease). Each of the compounds proved to be of vital importance in their therapeutic indication for numerous patients worldwide. This review also considers the mechanisms of side effects to deliver a complete perspective on current treatment options.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013829
- 003
- CZ-PrNML
- 005
- 20201104095508.0
- 007
- ta
- 008
- 170413s2016 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2174/0929867323666160525114026 $2 doi
- 035 __
- $a (PubMed)27222266
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Spilovska, Katarina
- 245 10
- $a Adamantane - A Lead Structure for Drugs in Clinical Practice / $c K. Spilovska, F. Zemek, J. Korabecny, E. Nepovimova, O. Soukup, M. Windisch, K. Kuca,
- 520 9_
- $a The adamantane moiety is the structural backbone of numerous compounds and its discovery launched a new field of chemistry studying the approaches to the synthesis as well as the physicochemical and biological properties of organic polyhedral compounds with practical application in the pharmaceutical industry. Adamantane derivatives have proven to be very potent compounds in a wide range of applications from systemic to topical therapy. This review summarizes the currently available adamantane derivatives in clinical practice (amantadine, memantine, rimantadine, tromantadine, adapalene, saxagliptin, vildagliptin), focusing on mechanisms of action, pharmacokinetics, pharmacodynamics and clinical trials. The adamantane-based compounds presented in this manuscript have been approved for a wide spectrum of indications (antivirals, antidiabetics and against Alzheimer's and Parkinson's disease). Each of the compounds proved to be of vital importance in their therapeutic indication for numerous patients worldwide. This review also considers the mechanisms of side effects to deliver a complete perspective on current treatment options.
- 650 _2
- $a adamantan $x analogy a deriváty $x farmakokinetika $x terapeutické užití $7 D000218
- 650 _2
- $a Alzheimerova nemoc $x farmakoterapie $7 D000544
- 650 _2
- $a antivirové látky $x chemie $x farmakokinetika $x terapeutické užití $7 D000998
- 650 _2
- $a diabetes mellitus 2. typu $x farmakoterapie $7 D003924
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypoglykemika $x chemie $x farmakokinetika $x terapeutické užití $7 D007004
- 650 _2
- $a chřipka lidská $x farmakoterapie $7 D007251
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Zemek, Filip
- 700 1_
- $a Korabecny, Jan
- 700 1_
- $a Nepovimova, Eugenie
- 700 1_
- $a Soukup, Ondrej
- 700 1_
- $a Windisch, Manfred
- 700 1_
- $a Kuca, Kamil $u Biomedical Research Centre, University Hospital, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. kamil.kuca@fnhk.cz.
- 773 0_
- $w MED00001274 $t Current medicinal chemistry $x 1875-533X $g Roč. 23, č. 29 (2016), s. 3245-3266
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27222266 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20201104095505 $b ABA008
- 999 __
- $a ok $b bmc $g 1200294 $s 974607
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 23 $c 29 $d 3245-3266 $i 1875-533X $m Current medicinal chemistry $n Curr Med Chem $x MED00001274
- GRA __
- $a NV15-30954A $p MZ0
- LZP __
- $a Pubmed-20170413